Product Description
Buy the new release Dasatinib 50 Mg Tablet-an unrivaled solution in cancer chemotherapy. This premier medication comes in a packaging size of 60 tablets per bottle and is prescribed exclusively for treating chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Featuring a wondrous round, film-coated tablet design, each contains Dasatinib 50 mg with other excipients. As a trusted exporter, supplier, and trader in India, we provide only US FDA-approved stock for indicated use. Order today and experience dependable efficacy. Prescription required. Store below 30C, protected from moisture and light. Not intended for use during pregnancy or breastfeeding unless necessary. Shelf life: 36 months.
Dasatinib 50 Mg Tablet: Usage & Applications
Dasatinib 50 Mg Tablet is primarily used as an oral cancer chemotherapy agent, prescribed for patients diagnosed with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It is used by oncologists and hematologists, and administered strictly under medical supervision. The tablet's high potency ensures targeted therapy, supporting critical cancer treatment regimens. Patients using this medication require a valid prescription due to its potent pharmacological properties and tailored usage protocols to ensure safety and therapeutic effectiveness.
Dasatinib 50 Mg Tablet: Packaging & Delivery Details
Each bottle contains 60 round, film-coated tablets, delivered securely with protection from moisture and light. We ensure timely delivery and maintain high supply ability to meet bulk and individual orders efficiently. Payment terms are flexible, with valuation based on order volume and destination. Every shipment is tracked to guarantee quality and compliance with regulatory standards, offering peace of mind to our clients. For reliable procurement and consistent supplies, our distribution network covers all regions of India and export destinations.
FAQ's of Dasatinib 50 Mg Tablet:
Q: How should Dasatinib 50 Mg Tablet be administered?
A: Dasatinib 50 Mg Tablet must be taken orally as directed by a specialized healthcare provider, typically once daily, with or without food.
Q: What are the main indications for using Dasatinib 50 Mg Tablet?
A: This tablet is indicated for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), as prescribed by an oncologist.
Q: When should Dasatinib 50 Mg Tablet not be used?
A: Dasatinib should not be used in patients with hypersensitivity to dasatinib or its components, and it is not recommended for pregnant or breastfeeding women unless absolutely necessary.
Q: Where is Dasatinib 50 Mg Tablet available for purchase?
A: The tablet is marketed in India and may be available in other countries depending on the manufacturer and local regulations, offered through us as exporter, supplier, and trader.
Q: What is the process of storing Dasatinib 50 Mg Tablets?
A: The tablets should be stored below 30C in their original packaging, protected from moisture and light to maintain stability throughout their 36-month shelf life.
Q: What are the common side effects associated with Dasatinib 50 Mg Tablet?
A: Common side effects include myelosuppression, edema, nausea, diarrhea, and rash. Patients should consult their healthcare provider for management advice.